Oxford Biomedica PLC OXBDF:OTCPK

*Data is delayed | Exchange | USD
Last | 05/07/24 EDT
3.86UNCH (UNCH)
52 week range
2.09 - 6.02
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.86
  • 52 Week High6.02
  • 52 Week High Date06/16/23
  • 52 Week Low2.09
  • 52 Week Low Date02/22/24

Key Stats

  • Market Cap410M
  • Shares Out100M
  • 10 Day Average Volume300
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change43.49

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.86
  • 52 Week High6.02
  • 52 Week High Date06/16/23
  • 52 Week Low2.09
  • 52 Week Low Date02/22/24
  • Market Cap410M
  • Shares Out100M
  • 10 Day Average Volume300
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change43.49

RATIOS/PROFITABILITY

  • EPS (TTM)-2.08
  • P/E (TTM)-1.86
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Oxford Biomedica PLC

 

Profile

MORE
Oxford Biomedica plc is a United Kingdom-based cell and gene therapy research, development and bio-processing company. The Company is engaged in providing services to third parties, as well as performing internal research and development for its own purposes. It performs a range of analytical assays within its in-house quality check (QC) labs. The Company operates through two segments: Platform and Product. Platform segment is involved in bio-processing and processes...
Roch Doliveux
Non-Executive Chairman of the Board
Frank Mathias
Chief Executive Officer, Executive Director
Nick Page
Chief Operating Officer
Stuart Paynter
Chief Financial Officer, Executive Director
James Miskin
Chief Technical Officer
Matthew Treagus
Chief Information Officer
Natalie Walter
General Counsel
Address
Windrush Court, Transport Way
Oxford
OX4 6LT
United Kingdom